Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology

Journal of Nutritional Biochemistry

Volumn 28, Issue , 2016, Pages 191-200

  Ojeda, Patricia ^a   Bobe, Alexandria ^a   Dolan, Kyle ^a   Leone, Vanessa ^a   Martinez, Kristina ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Circadian Rhythm; High fat diet; Inflammation; Metabolism; Microbiota; Obesity

Indexed keywords

BILE ACID; PREBIOTIC AGENT; PROBIOTIC AGENT;

ADIPOSE TISSUE; CALORIC INTAKE; CIRCADIAN RHYTHM; DIETARY INTAKE; DYSBIOSIS; FECES MICROFLORA; HOMEOSTASIS; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; LIVER FUNCTION; MACRONUTRIENT; METABOLIC DISORDER; METABOLIC REGULATION; NONHUMAN; NUTRITION; OBESITY; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; WESTERN DIET; XENOBIOTIC METABOLISM; ANIMAL; COMPLICATION; DIET; HUMAN; INTESTINE; LIVER; MICROBIOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DIET; DIET, WESTERN; HUMANS; INFLAMMATION; INTESTINES; LIVER; OBESITY; PREBIOTICS;

EID: 84957839898     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.08.013     Document Type: Review

References (84)

1. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303(3):235-241.
2. Pickett-Blakely O. Obesity and irritable bowel syndrome: a comprehensive review. Gastroenterol Hepatol (Y) 2014, 10(7):411-416.
3. Fock K.M., Khoo J. Diet and exercise in management of obesity and overweight. J Gastroenterol Hepatol 2013, 28(Suppl. 4):59-63.
4. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444(7122):1022-1023.
5. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005, 102(31):11070-11075.
6. Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3(4):213-223.
7. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027-1031.
8. Vrieze A., Van Nood E., Holleman F., Salojarvi J., Kootte R.S., Bartelsman J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143(4):913-916.
9. Koshy A.A., Bobe A.M., Brady M.J. Potential mechanisms by which bariatric surgery improves systemic metabolism. Transl Res 2013, 161(2):63-72.
10. Liou A.P., Paziuk M., Luevano J.M., Machineni S., Turnbaugh P.J., Kaplan L.M. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013, 5(178):178ra41.
11. David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505(7484):559-563.
12. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009, 1(6):6ra14.
13. Carmody R.N., Gerber G.K., Luevano J.M., Gatti D.M., Somes L., Svenson K.L., et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 2015, 17(1):72-84.
14. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007, 104(3):979-984.
15. Leone V., Gibbons S.M., Martinez K., Hutchison A.L., Huang E.Y., Cham C.M., et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe 2015, 17(5):681-689.
16. Rabot S., Membrez M., Bruneau A., Gerard P., Harach T., Moser M., et al. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 2010, 24(12):4948-4959.
17. Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S., Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 2010, 104(6):919-929.
18. Duca F.A., Swartz T.D., Sakar Y., Covasa M. Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One 2012, 7(6):e39748.
19. Martin C., Passilly-Degrace P., Gaillard D., Merlin J.F., Chevrot M., Besnard P. The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference. PLoS One 2011, 6(8):e24014.
20. Swartz T.D., Duca F.A., de Wouters T., Sakar Y., Covasa M. Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-expression and increased sucrose intake in mice lacking gut microbiota. Br J Nutr 2012, 107(5):621-630.
21. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101(44):15718-15723.
22. Louis P., Young P., Holtrop G., Flint H.J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 2010, 12(2):304-314.
23. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 2008, 105(43):16767-16772.
24. Kimura I., Ozawa K., Inoue D., Imamura T., Kimura K., Maeda T., et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 2013, 4:1829.
25. den Besten G., Havinga R., Bleeker A., Rao S., Gerding A., van Eunen K., et al. The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome. PLoS One 2014, 9(9):e107392.
26. Wichmann A., Allahyar A., Greiner T.U., Plovier H., Lunden G.O., Larsson T., et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 2013, 14(5):582-590.
27. Semova I., Carten J.D., Stombaugh J., Mackey L.C., Knight R., Farber S.A., et al. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe 2012, 12(3):277-288.
28. El Aidy S., Hooiveld G., Tremaroli V., Backhed F., Kleerebezem M. The gut microbiota and mucosal homeostasis: colonized at birth or at adulthood, does it matter?. Gut Microbes 2013, 4(2):118-124.
29. Chou C.J., Membrez M., Blancher F. Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice. Nestle Nutr Workshop Ser Pediatr Program 2008, 62:127-137.
30. Velagapudi V.R., Hezaveh R., Reigstad C.S., Gopalacharyulu P., Yetukuri L., Islam S., et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 2010, 51(5):1101-1112.
31. Jiang C., Xie C., Li F., Zhang L., Nichols R.G., Krausz K.W., et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest 2015, 125(1):386-402.
32. Castro B.M., Prieto M., Silva L.C. Ceramide: a simple sphingolipid with unique biophysical properties. Prog Lipid Res 2014, 54:53-67.
33. Harte A.L., da Silva N.F., Creely S.J., McGee K.C., Billyard T., Youssef-Elabd E.M., et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond) 2010, 7:15.
34. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772.
35. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481.
36. Dias-Melicio L.A., Fernandes R.K., Rodrigues D.R., Golim M.A., Soares A.M. Interleukin-18 increases TLR4 and mannose receptor expression and modulates cytokine production in human monocytes. Mediators Inflamm 2015, 2015:236839.
37. Devkota S., Wang Y., Musch M.W., Leone V., Fehlner-Peach H., Nadimpalli A., et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012, 487(7405):104-108.
38. Setchell K.D.R., Lawson A.M., Tanida N., Sjovall J. General methods for the analysis of metabolic profiles of bile acids and related compounds in feces. J Lipid Res 1983, 24(8):1085-1100.
39. Sayin S.I., Wahlstrom A., Felin J., Jantti S., Marschall H.U., Bamberg K., et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013, 17(2):225-235.
40. Swann J.R., Want E.J., Geier F.M., Spagou K., Wilson I.D., Sidaway J.E., et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4523-4530.
41. Watanabe Y., Nagai Y., Takatsu K. Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance. Nutrients 2013, 5(9):3757-3778.
42. Niehues M., Hensel A. In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?. J Pharm Pharmacol 2009, 61(10):1303-1307.
43. Carmody R.N., Turnbaugh P.J. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest 2014, 124(10):4173-4181.
44. Bjorkholm B., Bok C.M., Lundin A., Rafter J., Hibberd M.L., Pettersson S. Intestinal microbiota regulate xenobiotic metabolism in the liver. PLoS One 2009, 4(9):e6958.
45. Claus S.P., Ellero S.L., Berger B., Krause L., Bruttin A., Molina J., et al. Colonization-induced host-gut microbial metabolic interaction. MBio 2011, 2(2):e00271-10.
46. Haiser H.J., Seim K.L., Balskus E.P., Turnbaugh P.J. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 2014, 5(2):233-238.
47. Shen W., Gaskins H.R., McIntosh M.K. Influence of dietary fat on intestinal microbes, inflammation, barrier function and metabolic outcomes. J Nutr Biochem 2014, 25(3):270-280.
48. Lee J.Y., Hwang D.H. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells 2006, 21(2):174-185.
49. Kim F., Pham M., Luttrell I., Bannerman D.D., Tupper J., Thaler J., et al. Toll-like receptor-mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 2007, 100(11):1589-1596.
50. Pierre N., Deldicque L., Barbé C., Naslain D., Cani P.D., Francaux M. Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet. PLoS One 2013, 8(5):e65061.
51. Li J., Chen L., Zhang Y., Zhang W.J., Xu W., Qin Y., et al. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction. Acta Biochim Biophys Sin (Shanghai) 2013, 45(12):1030-1038.
52. Grossmann V., Schmitt V.H., Zeller T., Panova-Noeva M., Schulz A., Laubert-Reh D., et al. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 2015, 38(7):1356-1364. [2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered].
53. Fusaru A.M., Stanciulescu C.E., Surlin V., Taisescu C., Bold A., Pop O.T., et al. Role of innate immune receptors TLR2 and TLR4 as mediators of the inflammatory reaction in human visceral adipose tissue. Rom J Morphol Embryol 2012, 53(Suppl):693-701.
54. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341(6145):569-573.
55. den Besten G., Bleeker A., Gerding A., van Eunen K., Havinga R., van Dijk T.H., et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation. Diabetes 2015, [2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered]. 10.2337/db14-1213.
56. Kratz M., Coats B.R., Hisert K.B., Hagman D., Mutskov V., Peris E., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab 2014, 20(4):614-625.
57. Lottenberg A.M., Afonso M.a.S., Lavrador M.S., Machado R.M., Nakandakare E.R. The role of dietary fatty acids in the pathology of metabolic syndrome. J Nutr Biochem 2012, 23(9):1027-1040.
58. Kallio K.A., Hatonen K.A., Lehto M., Salomaa V., Mannisto S., Pussinen P.J. Endotoxemia, nutrition, and cardiometabolic disorders. Acta Diabetol 2015, 52(2):395-404.
59. Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 2013, 7(4):880-884.
60. de La Serre C.B., Ellis C.L., Lee J., Hartman A.L., Rutledge J.C., Raybould H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010, 299(2):G440-G448.
61. Krukenberg K.A., Kim S., Tan E.S., Maliga Z., Mitchison T.J. Extracellular poly(ADP-ribose) is a pro-inflammatory signal for macrophages. Chem Biol 2015, 22(4):446-452.
62. Bass J. Circadian topology of metabolism. Nature 2012, 491(7424):348-356.
63. Dibner C., Schibler U., Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 2010, 72:517-549.
64. Depner C.M., Stothard E.R., Wright K.P. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 2014, 14(7):507.
65. Buxton O.M., Cain S.W., O'Connor S.P., Porter J.H., Duffy J.F., Wang W., et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med 2012, 4(129):129ra43.
66. Mukherji A., Kobiita A., Ye T., Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 2013, 153(4):812-827.
67. Kohsaka A., Laposky A.D., Ramsey K.M., Estrada C., Joshu C., Kobayashi Y., et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 2007, 6(5):414-421.
68. Zarrinpar A., Chaix A., Yooseph S., Panda S. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab 2014, 20(6):1006-1017.
69. Thaiss C.A., Zeevi D., Levy M., Zilberman-Schapira G., Suez J., Tengeler A.C., et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell 2014, 159(3):514-529.
70. Voigt R.M., Forsyth C.B., Green S.J., Mutlu E., Engen P., Vitaterna M.H., et al. Circadian disorganization alters intestinal microbiota. PLoS One 2014, 9(5):e97500.
71. Mennigen R., Nolte K., Rijcken E., Utech M., Loeffler B., Senninger N., et al. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009, 296(5):G1140-G1149.
72. Everard A., Lazarevic V., Gaia N., Johansson M., Stahlman M., Backhed F., et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J 2014, 8(10):2116-2130.
73. De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014, 156(1-2):84-96.
74. Nilsson A., Johansson E., Ekstrom L., Bjorck I. Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study. PLoS One 2013, 8(4):e59985.
75. Xiao S., Fei N., Pang X., Shen J., Wang L., Zhang B., et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 2014, 87(2):357-367.
76. Wang J., Tang H., Zhang C., Zhao Y., Derrien M., Rocher E., et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 2015, 9(1):1-15.
77. Everard A., Matamoros S., Geurts L., Delzenne N.M., Cani P.D. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. MBio 2014, 5(3):e01011-e01014.
78. Aronsson L., Huang Y., Parini P., Korach-André M., Håkansson J., Gustafsson J., et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 2010, 5(9). 10.1371/journal.pone.0013087.
79. Ettinger G., MacDonald K., Reid G., Burton J.P. The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes 2014, 5(6):719-728.
80. Alisi A., Bedogni G., Baviera G., Giorgio V., Porro E., Paris C., et al. Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2014, 39(11):1276-1285.
81. Dhiman R.K., Rana B., Agrawal S., Garg A., Chopra M., Thumburu K.K., et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology 2014, 147(6):1327-1337.
82. Bakken J.S. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009, 15(6):285-289.
83. Bakken J.S., Borody T., Brandt L.J., Brill J.V., Demarco D.C., Franzos M.A., et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011, 9(12):1044-1049.
84. Tsilingiri K., Barbosa T., Penna G., Caprioli F., Sonzogni A., Viale G., et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut 2012, 61(7):1007-1015.